External
Imperial Collider returns, providing you the opportunity to meet world-leading researchers across Imperial's health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker is Dr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
8:30 - Registration and morning coffee
9:20 - Opening remarks
Mary Ryan, Vice Provost, Research and Enterprise, Imperial
9:30 - Opening keynote – Accessing innovation to drive the pharma pipeline
Fiona Marshall, President, Biomedical Research, Novartis
10:15 - Flagship Translational Journey I: The Discovery and Translation of GLP Biology
10:45 - Flagship Translational Journey II: A Rhinovirus Vaccine
Sebastian Johnston, Professor, Respiratory Medicine & Allergy, Imperial
11:15 - Morning break & networking
11:35 - Fleming in practice: tackling grand challenges in antimicrobial resistance
12:05 - Panel – Biomedical sector landscape and key trends
- Fiona Marshall, President, Biomedical Research, Novartis;
- Ruth McKernan, Operating Partner, SV Health Investors;
- Richard Mason, Chief Executive Officer, Apollo Therapeutics;
- Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher;
- Chair: Mike Romanos, Associate Dean for Enterprise, Imperial
12:55 - Lunch & networking
13:50 - Keynote – Innovation to enable the pharma industry and precision medicine
Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher
14:35 - Imperial’s clinical advantage: patients, cohorts and translational depth
Graham Cooke, Deputy Dean of the Faculty of Medicine, Imperial
14:55 - Convergence in practice: Digital health, data and the next frontier
Payam Barnaghi, Co-Director, School of Convergence Science (Human and Artificial Intelligence), Imperial College London
15:10 - Panel – Partnering that works: identifying science and building collaboration
- Kay Penicud, Vice President and Head of Research Partnerships, Apollo Therapeutics;
- Arjen Lemmen, VP Corporate Development & Strategy, Argenx;
- Malcolm Skingle, Former Head of Academic Liaison, GSK;
- Chair: Prasshy Jeyarajan, Head of Partnerships, Faculty of Medicine, Imperial
15:55 - Translational Science Showcase
16:50 - Closing reflections - Sustaining momentum beyond the Collider
Graham Cooke, Deputy Dean of Faculty of Medicine, Imperial
